Endometrial cancer: topicality of the issue and opportunities of rehabilitation


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Endometrial cancer is one of the most common gynecological cancers. The relevance of the topic is due to a rise in the number of reproductive-aged patients, which presents an acute sociomedical problem. The paper analyzes the possibilities of medical rehabilitation (diet therapy, physiotherapy, immunotherapy, etc.). It considers antitumor therapy complications that negatively affect female the life and health of women, such as sexual dysfunction, paraneoplastic fatigue syndrome, lower extremity lymphedema, radiation reactions, and postcastration syndrome, as well as methods for their correction. Methods for patient rehabilitation and early diagnosis of a relapse before its clinical manifestation are analyzed. The ultimate goal of rehabilitation is to improve quality of life in patients.

Full Text

Restricted Access

About the authors

L. Sandzhieva

I.M. Sechenov First Moscow State Medical University (Sechenov University)

L. Idrisova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

A. Solopova

I.M. Sechenov First Moscow State Medical University (Sechenov University); Oncology Clinical Hospital One, Moscow Healthcare Department

Email: antoninasolopova@yandex.ru

Yu. Tabakman

Oncology Clinical Hospital One, Moscow Healthcare Department

I. Ermakova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

References

  1. Ferlay J., Ervik M., Lam F. et al. GLOBOCAN 2018, GlobalCancerObservatory: CancerToday. LyonFrance: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today
  2. Morice P., Leary A., Creutzberg C. et al. Endometrial cancer // Lancet. -2016; 387 (10023): 1094-108. doi: 10.1016/S0140-6736(15)00130-0.
  3. Murali R., Soslow R., Weigelt B. Classification of endometrial carcinoma: more than two types // Lancet Oncol. - 2014; 15 (7): 268-78. doi: 10.1016/S1470-2045(13)70591-6.
  4. Солопова А.Г., Идрисова Л.Э., Макацария А.Д. и др. Мультидисциплинарный подход к медицинской реабилитации онкогинекологических больных // Акушерство, гинекология и репродукция. - 2017; 11 (4): 57-67 doi: 10.17749/2313-7347.2017.11.4.057-067.
  5. Graziottin A., Lukasiewicz M., Serafini A. Sexual Rehabilitation After Gynaecological Cancers // Cancer Int. Sex. - 2017; 205-222. doi: 10.1007/978-3-319-43193-2_27.
  6. Huiqiao G., Meizhu X., Huimin B. et al. Sexual Function and Quality of Life Among Patients With Endometrial Cancer After Surgery // Int. J. Cancer. - 2017; 27 (3): 608-12. doi: 10.1097/igc.0000000000000905.
  7. Del Pup. L., Villa P., Amar I. et al. (2019). Approach to sexual dysfunction in women with cancer // Int. J. Gynecol. Cancer. - 2019; 29 (3): 630-4. DOI: 10.1136/ ijgc-2018-000096.
  8. Pagano I., Gieri S., Nocera F. et al. Evaluation of the CO2 Laser Therapy on Vulvo-Vaginal Atrophy (VVA) in Oncological Patients: Preliminary Results // J. Cancer Ther. - 2017; 8 (5): 452-63. doi: 10.4236/jct.2017.85039.
  9. Stahl J., Qian J., Tien C. et al. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy // Supp. Care Cancer. - 2018; 27: 1425. doi: 10.1007/s00520-018-4441-5.
  10. Delia P., Sansotta G., Pontoriero A. et al. Clinical Evaluation of Low-Molecular- Weight Hyaluronic Acid-Based Treatment on Onset of Acute Side Effects in Women Receiving Adjuvant Radiotherapy after Cervical Surgery: A Randomized Clinical Trial // Oncol. Res. Treat. - 2019; 42 (4): 217-23. doi: 10.1159/000496036.
  11. Пилипенко Н.И., Прохач Н.Э. Качество жизни и синдром паранеопластической усталости у онкологических больных // Евразийский онкол. журн. - 2014; 1 (1): 68-76
  12. Lokich E. Gynecologic Cancer Survivorship // Obstet. Gynecol. Clin. North Am. - 2019; 46 (1): 165-78. doi: 10.1016/j.ogc.2018.10.002.
  13. Rossi E., Noberasco C., Picchi M. et al. Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy // J. Altern. Complement Med. - 2018; 24 (9-10): 933-41. doi: 10.1089/acm.2018.0143.
  14. Cochen C., Fontaine K., Arend R. et al. Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial // Nutrients. - 2018; 10: 1187. doi: 10.3390/nu10091187.
  15. Do J., Choi K., Ahn J. et al. Effects of a complex rehabilitation program on edema status, physical function, and quality of life in lower-limb lymphedema after gynecological cancer surgery // Gynecol. Oncol. - 2017; 147 (2): 450-5. doi: 10.1016/j.ygyno.2017.09.003.
  16. Beesley V., Rowlands I., Hayes S. et al. Incidence, risk factors and estimates of a woman’s risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer // Gynecol. Oncol. - 2015; 136 (1): 87-93. doi: 10.1016/j.ygyno.2014.11.006.
  17. Thomaz J., Dias T., de Rezende L. Effect of taping as treatment to reduce breast cancer lymphedema: literature review // J. Vasc. Bras. - 2018; 17 (2): 136 40. doi: 10.1590/1677-5449.007217
  18. Janicki J., Chancellor M., Kaufman J. et al. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction // Toxins. - 2016; 8 (3): 81. doi: 10.3390/toxins8030081.
  19. Wei D., Heus P., van de Wetering F. et al. Probiotics for the prevention or treatment of chemotherapy- or radiotherapy-related diarrhoea in people with cancer // Cochrane Database Syst. Rev. - 2018; 8: CD008831. doi: 10.1002/14651858.CD008831.pub3.
  20. Cui M., Xiao H., Li Y. et al. Faecal microbiota transplantation protects against radiation-induced toxicity // EMBO Mol. Med. - 2017; 9 (4): 448-61. doi: 10.15252/emmm.201606932.
  21. Edey K., Rundle S., Hickey M. Hormone replacement therapy for women previously treated for endometrial cancer (Review) // Cochrane Database Syst. Rev. - 2018; CD008830. doi: 10.1002/14651858.CD008830.pub3.
  22. Angioli R., Luvero D., Armento G. et al. Hormone replacement therapy in cancer survivors: Utopia? // Crit. Rev. Oncol. Hematol. - 2018; 124: 51-60. doi: 10.1016/j.critrevonc.2018.02.005.
  23. Hickey M., Szabo R., Hunter M. Non-hormonal treatments for menopausal symptoms // BMJ. - 2017; 359: j5101. doi: 10.1136/bmj.j5101.
  24. Булах О.А., Филатова Е.В. Комплексная реабилитация пациенток с посткастрационным синдромом // Физиотерапия, бальнеология и реабилитация. - 2017; 16 (5): 249-53 doi: 10.18821/16813456-2017-16-5-249-253.
  25. Кит О.И., Франциянц Е.М., Моисеенко Т.И. и др. Роль плазмафереза и ксенонтерапии в коррекции острых последствий хирургической менопаузы у больных раком шейки матки // Научный журнал КубГАУ. - 2016; 117 (03)
  26. Sun X-L., Wang H-B., Wang Z-Q. et al. Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial // BMC Cancer. - 2017; 17: 416. doi: 10.1186/s12885-017-3387-1.
  27. Улащик В.С. Локальная гипертермия в онкологии: использование магнитного поля, лазерного излучения, ультразвука // Вопросы курортологии, физиотерапии и лечебной физической культуры. - 2014; 91 (2): 48-57
  28. Степанова А.М., Мерзлякова А.М., Ткаченко Г.А. и др. Физиотерапия, механотерапия и психотерапия в онкологии // Вестн. восст. мед. - 2016; 5: 42-6
  29. Литвинова Т.М., Косенко И.А., Залуцкий И.В. и др. Противоопухолевое и противометастатическое действие внутривенного лазерного облучения крови: экспериментальное доказательство и использование при раке тела матки // Лазерная мед. - 2012; 16 (3): 13-8
  30. Грушина Т.И., Миронова Е.Е. Санаторно-курортное лечение в комплексе реабилитационных мероприятий у больных раком молочной железы // Физиотерапия, бальнеология и реабилитация. - 2003; 4: 34-8
  31. Круглова Л.С., Шатохина Е.А., Котенко К.В. и др. Использование физиотерапевтических методов в реабилитации больных с онкологической патологией // Физиотерапия, бальнеология и реабилитация. - 2016; 15 (2): 97-101 doi: 10.18821/1681-3456-2016-15-2-97-101.
  32. Sorbe B., Juresta C., Ahlin C. Natural history of recurrences in endometrial carcinoma // Oncol. Lett. - 2014; 8 (4): 1800-6. doi: 10.3892/ol.2014.2362.
  33. Brennan D., Hackethal A., Mann K. et al. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance // BMC Cancer. - 2015; 15: 33. doi: 10.1186/s2885-015-1028-0.
  34. Enqerud H., Hope K., Berq H. et al. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer // PLoS One. - 2019; 14 (1): e0210585. doi: 10.1371/journal.pone.0210585.
  35. Troisi J., Sarno L., Landolfi A. et al. Metabolomic signature of endometrial cancer // J. Proteome Res. - 2018; 17 (2): 804-12. doi: 10.1021/acs. jproteome.7b00503.
  36. Knific T., Vouk K., Smrkolj S. et al. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer // J. Steroid Biochem. Mol. Biol. - 2018; 178: 312-21. doi: 10.1016/j.jsbmb.2018.01.012.
  37. Longoria T., Escander R. Immunotherapy in endometrial cancer - an evolving therapeutic paradigm // Gynecologic Oncology Research and Practice. -2015; 2: 11. doi: 10.1186/s40661-015-0020-3.
  38. Jackson D., Byrd K., Vreeland T. Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients // Oncotarget. - 2017; 8 (9): 15912-23. doi: 10.18632/oncotarget.13305.
  39. Coosemans A., Vanderstraeten A., Tuyaerts S. Wilms’ Tumor Gene 1 (WT1) - loaded Dendritic Cell Immunotherapy in Patients with Uterine Tumors: A Phase I/II Clinical Trial // Anticancer Res. - 2013; 33: 5495-500.
  40. Gopalakrishnan V., Helmink B., Spencer C. et al. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy // Cancer Cell. -2018; 33 (4): 570-80. doi: 10.1016/j.ccell.2018.03.015.
  41. Zitvogel L., Ma Y., Raoult D. et al. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies // Science. - 2018; 359 (6382): 136670. doi: 10.1126/science.aar6918.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies